Floresan Anti-Couperose Day Cream SPF 20 with Omega 3-6-9 for Sensitive Skin – 65ml
Description:
Target persistent facial redness and strengthen your skin with the high-performance . Specifically formulated for hypersensitive and reactive skin, this therapeutic day cream is designed to prevent and combat the early stages of couperose, rosacea, and visible spider veins. It works effectively to calm irritation and unify your natural skin tone.
Powered by highly concentrated Omega 3-6-9 polyunsaturated fatty acids, this cream is enriched with potent Horse Chestnut extract and an essential vitamin complex (Vitamins C, P, and K). This professional blend deeply penetrates to reinforce capillary walls, improve microcirculation, and reduce the visibility of dilated blood vessels on the cheeks and nose. Infused with light-reflecting pearlescent particles, it visually color-corrects redness upon application, while broad-spectrum SPF 20 filters protect fragile skin from UV damage, which can worsen vascular issues.
Key Features:
- Anti-Redness & Capillary Care: Effectively targets and diminishes the appearance of couperose and facial spider veins.
- Omega 3-6-9 & Vitamin Complex: Enriched with Vitamins C, P, and K to enhance blood vessel elasticity and nourish deep skin layers.
- Instant Visual Correction: Formulated with micro-pearl particles that instantly neutralize redness for a radiant, even complexion.
- Daily UV Shield SPF 20: Limits ultraviolet exposure to prevent damage to compromised and reactive skin barriers.
- Perfect Makeup Base: Non-greasy, lightweight texture that absorbs smoothly, serving as an excellent daily primer for sensitive skin.
How to Use:
Apply the cream every morning to thoroughly cleansed, dry facial skin. Smooth an even layer over the entire face, paying special attention to problematic areas prone to redness and visible capillaries (such as the cheeks and sides of the nose). Gently massage until fully absorbed. Can be used alone or as an ideal base for makeup.





Reviews
There are no reviews yet.